2025
$7.11
▼
OE = CFO - dWC - SBC - maintenance capex, GE Aerospace continuing operations only. CFO (continuing ops)=$8,543M; dWC (receivables -2,437, inventories -1,981, contract assets -511, contract liabilities +1,066, progress collections +838, accounts payable +1,993, sales discounts +562)=-$470M, removed (adds back 470); SBC=$325M; capex=$1,273M; growth capex=2.538% x (45,855-38,702)=$181.6M so maintenance capex=$1,091.4M; OE=8,543+470-325-1,091.4=$7,596.6M; diluted shares=1,068M; OE/sh=$7.11. Cash interest paid (InterestPaidNet)=$882M, so business cash flow before lenders=$8,478.6M or $7.94/sh. Source: FY2025 10-K, accession 0000040545-26-000008.
2024
$4.83
▼
OE = CFO - dWC - SBC - maintenance capex, GE Aerospace continuing operations only. CFO (continuing ops)=$5,817M (2024 carried higher separation and restructuring charges than 2025: separation costs $492M vs $202M, per the FY2025 10-K); dWC (receivables -1,076, inventories -1,528, contract assets -112, contract liabilities +1,066, progress collections +531, accounts payable +688, sales discounts -266)=-$697M, removed (adds back 697); SBC=$286M; capex=$1,032M; growth capex=2.538% x (38,702-35,348)=$85.1M so maintenance capex=$946.9M; OE=5,817+697-286-946.9=$5,281.1M; diluted shares=1,094M; OE/sh=$4.83. Source: FY2025 10-K, accession 0000040545-26-000008.
2023
$3.00
▼
OE = CFO - dWC - SBC - maintenance capex, GE Aerospace continuing operations only. CFO (continuing ops)=$4,609M; dWC (receivables -210, inventories -1,321, contract assets -27, contract liabilities +1,226, progress collections +242, accounts payable +713, sales discounts -203)=+$420M, removed; SBC=$192M; capex=$862M; capex ratio=mean(capex/revenue 2022-2025)=2.538%; growth capex=2.538% x (35,348-29,139)=$157.6M so maintenance capex=$704.4M; OE=4,609-420-192-704.4=$3,292.6M; diluted shares=1,099M; OE/sh=$3.00. Source: FY2025 10-K, accession 0000040545-26-000008.
2022
$1.90
▼
OE = CFO - dWC - SBC - maintenance capex, GE Aerospace continuing operations only (GE HealthCare and GE Vernova are discontinued operations, so pre-2022 conglomerate figures are not comparable and were not stored). CFO (continuing ops)=$4,027M; dWC (net cash effect of changes in operating working capital: receivables -1,875, inventories -980, contract assets +36, contract liabilities +1,075, progress collections +1,187, accounts payable +1,639, sales discounts +47)=+$1,129M, removed; SBC=$143M; capex (PP&E and internal-use software)=$662M; no prior-year restated revenue on this basis so growth capex=$0 and maintenance capex=$662M; OE=4,027-1,129-143-662=$2,093M; diluted shares=1,101M; OE/sh=$1.90. Source: FY2024 10-K (as restated for the Vernova separation), accession 0000040545-25-000015.
Owner's earnings per share by fiscal year, most recent first. Tap a row to see how that figure was calculated, including the source filing.